Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07267117Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Role: collaborator

NCT05979935Active Not Recruiting

A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis

Role: collaborator

NCT06696404Not ApplicableCompleted

The Role of Precision Anesthesia Strategy on Perioperative Organ Protection in Hip Surgery [PASPOP]

Role: collaborator

NCT06696248Phase 2Not Yet Recruiting

Carvedilol and Alverine in Portal Hypertension

Role: collaborator

NCT06354530Phase 2Recruiting

A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Role: lead

NCT06329999Not ApplicableRecruiting

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

Role: collaborator

NCT05489055Not ApplicableUnknown

Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA

Role: collaborator

NCT02485275Completed

Stroke Imaging Package Study

Role: collaborator

All 8 trials loaded